ArticleJournal of inflammation research2025
Predicting Superaverage Length of Stay in COPD Patients with Hypercapnic Respiratory Failure Using Machine Learning.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hypercapnia, Prognostic Nutritional Index and Length of Stay in Acute Exacerbation of COPD: A Two-Variable Admission Framework.Diagnostics (Basel, Switzerland) · 2026Article
- Hypercapnia is associated with an increased risk of ICU admission and reduced inflammatory responses in AECOPD patients with severe pneumonia.Therapeutic advances in respiratory diseaseObservational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The purpose of this study was to develop and validate machine learning models that can predict superaverage length of stay in hypercapnic-type respiratory failure and to compare the performance of each model. Furthermore, screen and select the optimal individualized risk assessment model. This model is capable of predicting in advance whether an inpatient's length of stay will exceed the average duration, thereby enhancing its clinical application and utility. Methods: The study included 568 COPD patients with hypercapnic respiratory failure, 426 inpatients from the Department of Respiratory and Critical Care Medicine of Yancheng First People's Hospital in the modeling group and 142 inpatients from the Department of Respiratory and Critical Care Medicine of Jiangsu Provincial People's Hospital in the external validation group. Ten machine learning algorithms were used to develop and validate a model for predicting superaverage length of stay, and the best model was evaluated and selected. Results: We screened 83 candidate variables using the Boruta algorithm and identified 9 potentially important variables, including: cerebrovascular disease, white blood cell count, hematocrit, D-dimer, activated partial thromboplastin time, fibrin degradation products, partial pressure of carbon dioxide, reduced hemoglobin, and oxyhemoglobin. Cerebrovascular disease, hematocrit, activated partial thromboplastin time, partial pressure of carbon dioxide, reduced hemoglobin and oxyhemoglobin were independent risk factors for superaverage length of stay in COPD patients with hypercapnic respiratory failure. The Catboost model is the optimal model on both the modeling dataset and the external validation set. The interactive web calculator was developed using the Shiny framework, leveraging a predictive model based on Catboost. Conclusion: The Catboost model has the most advantages and can be used for clinical evaluation and patient monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.